This is a review of the preclinical efficacy testing of new antituberculosis drug candidates. It describes existing dynamic in vitro and in vivo models of antituberculosis chemotherapy and their utility in preclinical evaluations of promising new drugs and combination regimens, with an effort to highlight recent developments. Emphasis is given to the integration of quantitative pharmacokinetic/pharmacodynamic analyses and the impact of lesion pathology on drug efficacy. Discussion also includes in vivo models of chemotherapy of latent tuberculosis infection.
|Original language||English (US)|
|State||Published - Jun 1 2017|
ASJC Scopus subject areas
- Immunology and Microbiology(all)
- Microbiology (medical)
- Cell Biology
- Infectious Diseases